Drugs / MVA-MERS-S_DF1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04119440 | Apr 2021 → Nov 2022 | Middle East respiratory syndrome | University Medical Center Hamburg-Eppendorf | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MVA-MERS-S_DF-1 | “Candidate Vaccine MVA-MERS-S_DF-1 Against MERS” NCT04119440 ↗ |